Novartis AG (CHIX:NOVNZ) Dividend Payout Ratio: (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:NOVNZ Novartis AG CHIX:NOVNZ
80 GF Score
Price CHF115.28
GF Value CHF107.71
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Novartis AG Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Novartis AG's Dividend Payout Ratio for the months ended in Jun. 2026 was .

The historical rank and industry rank for Novartis AG's Dividend Payout Ratio or its related term are showing as below:

CHIX:NOVNz' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.33   Med: 0.84   Max: 1.19
Current: 0.69

During the past 13 years, the highest Dividend Payout Ratio of Novartis AG was 1.19. The lowest was 0.33. And the median was 0.84.

CHIX:NOVNz's Dividend Payout Ratio is ranked worse than
78.6% of 444 companies
in the Drug Manufacturers industry
Industry Median: 0.38 vs CHIX:NOVNz: 0.69

As of today (2026-09-20), the Dividend Yield % of Novartis AG is 3.21%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Novartis AG was 4.61%. The lowest was 2.69%. And the median was 3.83%.

Novartis AG's Dividends per Share for the months ended in Jun. 2026 was CHF.

During the past 12 months, Novartis AG's average Dividends Per Share Growth Rate was 3.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 0.40% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 3.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 1.90% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Novartis AG was 18.50% per year. The lowest was 0.00% per year. And the median was 5.30% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Novartis AG (CHIX:NOVNz) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Novartis AG Dividend Payout Ratio Related Terms

Novartis AG Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Novartis AG's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis AG Dividend Payout Ratio Chart

Novartis AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.75 0.44 0.61 0.59

Novartis AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 3.22 - -

CHIX:NOVNZ vs LLY, JNJ, ABBV: Dividend Payout Ratio Comparison

For the Drug Manufacturers - General subindustry, Novartis AG's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novartis AG Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Novartis AG's Dividend Payout Ratio falls into.


CHIX:NOVNZ
80GF Score
Novartis AG CHIX:NOVNZ
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novartis AG Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Novartis AG's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=3.7/ 6.280302621744
=0.59

Novartis AG's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=/ 1.5502159106783
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Novartis AG (CHIX:NOVNZ) Overvalued in 2026?

Based on GuruFocus' analysis, Novartis AG stock appears to be overvalued. The current stock price of CHF115.28 is trading 7% above its estimated GF Value™ of CHF107.71. GuruFocus considers Novartis AG to be Fairly Valued.

Key valuation signals for CHIX:NOVNZ:

  • Dividend Payout Ratio:
  • GF Value™: CHF107.71 vs. price of CHF115.28 (7% above fair value)
  • GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the CHIX:NOVNZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novartis AG Business Description

Address Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
80GF Score

Get the complete analysis for CHIX:NOVNZ

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF115.28
Price
CHF107.71
GF Value